NIH Clinical Center: Search the Studies

Search the Studies

18 Studies found from all possible combinations of your search terms. Select a protocol that you wish to review.

Protocol Number	Title	Protocol Status	Min-Max Age	Institute	Keywords
000494-DK	Natural History of Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment	Participants currently recruited/enrolled	18-125 Years	NIDDK	Duct
000473-C	A Randomized Phase II Study of Systemic Chemotherapy with or without HAI FUDR-Dexamethasone in Patients with Unresectable Intrahepatic Cholangiocarcinoma	Participants currently recruited/enrolled	18-125 Years	NCI	Duct
000307-C	Phase II Study Evaluating the Efficacy of M9241 in Combination with Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects with Metastatic Colorectal Cancer or Intrahepatic Cholangiocarcinoma	Participants currently recruited/enrolled	18-125 Years	NCI	Duct
000254-C	A Phase II Trial of the Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP)	Participants currently recruited/enrolled	18-125 Years	NCI	Duct
000194-C	A Phase I Trial of ProAgio, an anti- alpha-v-beta3 Integrin Cytotoxin, for Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies	Participants currently recruited/enrolled	18-125 Years	NCI	Duct
000130-DK	Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach	Participants currently recruited/enrolled	18-125 Years	NIDDK	Duct
21-C-0006	Phase I/II Study Evaluating Safety and Efficacy of Tivozanib (AV-951) in Cholangiocarcinoma	Clinical hold/Recruitment or enrollment suspended	18-125 Years	NCI	Duct
20-C-0152	Phase II Study of combination of Trametinib (MEK inhibitor) and Hydroxychloroquine (HCQ) (autophagy inhibitor) in Patients with KRAS Mutation Refractory Bile Tract Carcinoma (BTC).	Participants currently recruited/enrolled	18-125 Years	NCI	Duct
19-C-0016	Natural History and Biospecimen Acquisition Study for Children and Adults with Rare Solid Tumors	Participants currently recruited/enrolled	0-125 Years	NCI	Duct
16-C-0135	A Pilot Study of Combined Immune Checkpoint Inhibition in combination with Ablative Therapies in Subjects with Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)	No longer recruiting/follow-up only	18-125 Years	NCI	Duct
16-C-0128	A Phase I/II Study of Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination with Nab-Paclitaxel in Participants with Previously Treated Metastatic and/ or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid Tumors	Completed Study; data analyses ongoing	18-125 Years	NCI	Duct
15-D-0129	Open-Label, Dose-Escalation Study Evaluating the Safety of a Single Administration of an Adeno-Associated Virus Vector Encoding Human Aquaporin-1 to One Parotid Salivary Gland in Individuals with Irradiation-Induced Parotid Salivary Hypofunction.	Participants currently recruited/enrolled	18-125 Years	NIDCR	Duct
15-D-0051	Characterization of Diseases with Salivary Gland Involvement	Participants currently recruited/enrolled	4-125 Years	NIDCR	Duct
13-H-0059	Longitudinal Observational Study of Severe Asthma	Participants currently recruited/enrolled	18-125 Years	NHLBI	Obstruction
13-C-0176	Tumor, Normal Tissue and Specimens from Patients Undergoing Evaluation or Surgical Resection of Solid Tumors	Participants currently recruited/enrolled	2-125 Years	NCI	Duct
08-EI-0102	Screening Protocol for the Evaluation and Diagnosis of Potential Research Participants	Participants currently recruited/enrolled	2-125 Years	NEI	Lacrimal
03-C-0066	Hereditary Leiomyomatosis Renal Cell Cancer (HLRCC): Identification of the Disease Gene, and Characterization of the Predisposition to Renal Cancer	Participants currently recruited/enrolled	2-125 Years	NCI	Duct
01-C-0009	Breast Imaging Screening Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-up Study	Completed Study; data analyses ongoing	18-100 Years	NCI	Duct